Phoenix Biotech

Cantor webinar For decades #BBB has been the largest barrier to CNS drug development new #delivery #platforms, partnerships suggests growing momentum behind technologies designed to actively transport therapeutics across the BBB. ... re $SGMO STAC-BBB $LLY , Roche , Astellas ...

$XBI A Special Webinar With @adamfeuerstein Adam Feuerstein (@statnews News) and @biotech1 Adam shared his perspectives on a variety of topics: current FDA environment, What companies can do to build credibility, His approach to investigative journalism cantor.zoom.us/rec/share/4GTe…

🚨BREAKING: AfD leader Alice Weidel EXPOSES the EU's globalist elite: "They flood our countries with illegal migrants and force our own people to feed and house them, all while terrorism stalks our street, crime explodes, and Islamic extremism takes root." 🇩🇪

Are you ready to shape the future of public health at the highest levels? The FDA is seeking an exceptional executive leader to serve as the Center Director for CBER—a role at the forefront of regulating life-saving biological products, vaccines, and emerging therapies. This is an opportunity to protect and advance public health on a national scale. You'll work on cutting-edge science, shape critical regulatory policy, and lead a team dedicated to ensuring the safety and effectiveness of biological products that save lives. Apply by April 3, 2026. #FDAJobs usajobs.gov/job/862056100?…

@staycaffeinated @musksamerica @SangamoTx yeah but why should they ... 1 year data exepted and confirmed at any meeting .. i guess no adcom and fastest approval of a gt ever

@BiotechAnalysst @musksamerica @SangamoTx They’ll ask for whatever they want during the review.

$SGMO @SangamoTx HOW ABOUT ANNOUNCING SOMETHING POSITIVE .. IF YOU REVERSE SPLIT THIS STOCK I WILL FILE A MASSIVE LAWSUIT.. DATA WE NEED POSITIVE DATA AND A DEAL

$BBIO --> $SGMO

@staycaffeinated @musksamerica @SangamoTx they wont ask for more ... 2 year data will be completed in april ...

@musksamerica @SangamoTx Unless fda asks for more during review clock

„Diesmal kommt die Gefahr nicht von außen. Sie kommt von innen. Von den globalistischen Eliten in Brüssel und in viel zu vielen europäischen Hauptstädten — und gerade weil sie die Maske des Wohlwollens trägt, ist sie so teuflisch gefährlich." #CPAC2026

$EYPT suing $OCUL. sec.gov/ix?doc=/Archiv…

For some drugs, new technology can predict toxicity better than animals—it’s also more humane.

the leader in BBB capsids $SGMO is now called "and others" by Stifel ... #cancelculture

Some interesting comments from Jacob Van Naarden, $LLY head of business development, at STAT's Breakthrough Summit East event yesterday: On deal volume: Jake, himself, is seeing approx 10 deals per week, ie deals that are important enough, or diligenced enough, to cross his desk. "We are making more offers than you can possibly imagine. Either me personally or members of my team are making between three and five offers a week to either license something or buy a company or do some kind of discovery deal. Of course, you haven't read about all those because they don't all end up happening..." Why don't all these deals get done? A lot of deals are small, or involve private companies or preclinical assets, are not press released, etc etc... However, when it comes to public company deals... Jake: "What's interesting is how many of the multi-billion dollar deals we are attempting to do, and sort of get rebuffed with some frequency..." He added... "We engage with a lot of publicly traded companies... and those are the ones where I'm particularly surprised you put sort of a market premium offer on the table, and you're not even granted a conversation, so to speak, as you have a conversation, but it sort of doesn't go anywhere. That's pretty surprising, and that's that's happening more frequently than I would have expected."

Cantor webinar For decades #BBB has been the largest barrier to CNS drug development new #delivery #platforms, partnerships suggests growing momentum behind technologies designed to actively transport therapeutics across the BBB. ... re $SGMO STAC-BBB $LLY , Roche , Astellas ...

Breaching The Fortress: The New Wave of Companies Cracking The Blood Brain Barrier $DNLI $SGMO $VYGR $IONS beacon-intelligence.com/blog/breaching…

*US MAKING PREPARATIONS FOR POTENTIAL GROUND TROOPS IN IRAN: CBS *OIL PRICES RISE AFTER REPORT US PREPARES GROUND TROOPS IN IRAN

Wonder if $BBIO BridgeBio could be a partner for #Fabry , at least in the US,  and maybe Takeda for ex US. Maybe she knows something we do not know yet ......??? She is also presenting next week for Sangam,o at the 3. Human Gene Therapy Conference March 23-25

$sgmo

$XBI Endpoints' Headlines look mostly positive to me $QURE CLS says #Hemophilia B GENE THERAPY out of stock , warns of treatment delays ... $SGMO Hemophilia could be a blockbuster too one day

OPEX today ... lets make $SGMO squeeze and close at .50